Priapism

Priapism is a potentially painful medical condition, in which the erect penis or clitoris does not return to its flaccid state.

Sickle Cell Disease
Paolo Aquino, M.D., M.P.H.,
http://www.med.wayne.edu

Medical Emergencies - Urology and Nephrology Topics
http://web.uaccb.edu

Case Study
http://www.meddean.luc.edu

Sickle Cell Disease
http://users.phhp.ufl.edu

Antiestrogens, Antiprogestins, and Androgens Drugs Affecting Fertility and Reproduction
Gerianne R. Bliss, M.D., Chuck Hensley, R.Ph.
http://cmsu2.ucmo.edu

Sickle Cell Disease: Pain & Fever
John Cheng, MD
http://www.pediatrics.emory.edu

Inflammatory Disorders of the Male
Penne Mott
http://intranet2.dpe.edu

Male GU Disorders
http://cstl-hhs.semo.edu

Sickle Cell and Transfusions
Ashley Duckett, MD
http://clinicaldepartments.musc.edu

Sickle Cell Disease
By Brent Durschmidt
http://faculty.chemeketa.edu

One for You and One for Me: Drug Seeking Patients and Professionals
Frank Paloucek PharmD DABAT
http://www.pitt.edu

Sickle Cell Anemia
http://www.rcc.mass.edu

Head and Spine Injuries
http://faculty.sgc.edu

Polycythemia and Hyperviscosity
Kirsten E. Crowley, MD
http://www.ohsu.edu

Sex organs of the male
http://campus.houghton.edu

Pediatric Hematological Disorders
Whaley and Wong
http://ruby.fgcu.edu

Antidepressants
Cesar A. Soutullo, M.D.
http://www.hsc.wvu.edu

Suspected Spinal Injury
http://web.monroecc.edu

Trauma Emergencies
http://web.uaccb.edu 


600 Published articles on Priapism

1. Molecular Analysis of Erection Regulatory Factors in Sickle Cell Disease-Associated Priapism in Human Penis.
2. Priapism: pathophysiology and the role of the radiologist.
3. Priapism in antipsychotic drug use: a rare but important side effect.
4. Algorithm for initial management of priapism in chronic myeloid leukaemia.
5. Pre-embolization evaluation of high-flow priapism: magnetic resonance angiography of the penis.
6. Unsatisfactory outcomes of prolonged ischemic priapism without early surgical shunts: our clinical experience and a review of the literature.
7. Partial priapism secondary to idiophatic segmental thrombosis of corpora cavernosa.
8. Priapism is Associated with Sleep Hypoxemia in Sickle Cell Disease.
9. Priapism in an Infant With Sickle Cell Trait After Cardiac Transplant.
10. Priapism: comorbid factors and treatment outcomes in a contemporary series.
11. Re: Conversion of Low-Flow to High-Flow Priapism: A Case Report and Review.
12. Phoneutria nigriventer spider toxin Tx2-6 causes priapism and death: A histopathological investigation in mice.
13. Priapism as the Initial Manifestation of a Penile and Lower Limb Cutaneous Metastasis of Prostate Adenocarcinoma with Low Serum PSA Level: A Case Report.
14. Stuttering priapism: insights into pathogenesis and management.
15. Priapism, pomegranate juice, and sildenafil: Is there a connection?
16. An adolescent with sickle cell anaemia experiencing disease-related complications: priapism and leg ulcer--a management challenge.
17. Priapism secondary to involvement of corpora cavernosa by locally advanced prostate cancer.
18. How I manage priapism in chronic myeloid leukaemia patients.
19. Moxonidine-induced priapism in an autosomal-dominant polycystic kidney disease dialysis patient.
20. The prevalence of priapism in children and adolescents with sickle cell disease in Brazil.
21. A rare but significant cause of priapism in the elderly: multiple myeloma.
22. Acute management of priapism in men.
23. Standard Operating Procedures for Priapism.
24. Conversion of low-flow to high-flow priapism: a case report and review (CME).
25. Case of malignant priapism and review of the literature.
26. Re: Early insertion of inflatable prosthesis for intractable ischemic priapism: our experience and review of the literature.
27. Postsurgical high flow priapism treated by transarterial embolizaton: a case report.
28. Post-traumatic penile pseudoaneurysm causing high-flow priapism.
29. Priapism as an initial presentation of chronic lymphocytic leukemia.
30. Priapism in acute spinal cord injury.
31. Surgical management of ischemic priapism.
32. Nonischemic priapism following penile tattooing.
33. Evaluation and management of priapism in a newborn: A case report and review of the literature.
34. Re: Early insertion of inflatable prosthesis for intractable ischemic priapism: our experience and review of the literature.
35. A minimally invasive temporary cavernoso-saphenous shunt in the management of priapism after failed conservative treatment.
36. Achieving detumescence of ischemic priapism with intra-cavernosal injection of fentanyl: an unexpected outcome of miscommunication error.
37. Re: A Prospective Diary Study of Stuttering Priapism in Adolescents and Young Men With Sickle Cell Anemia: Report of an International Randomized Control Trial; the Priapism in Sickle Cell Study (PISCES study).
38. [Emergency checklist: Priapism].
39. Medical management of ischemic stuttering priapism: a contemporary review of the literature.
40. [Priapism in pediatrics: initial presentation of chronic myeloid leukemia].
41. The use of sudafed for priapism in pediatric patients with sickle cell disease.
42. [Posttraumatic high flow priapism: successful treatment with superselective embolization].
43. [A patient suffering from priapism as a side-effect of pipamperone].
44. Penile gangrene: an unusual complication of priapism in a patient with bladder carcinoma.
45. Priapism associated with Niemann-Pick disease in a 15-year-old boy.
46. Post-traumatic pre-pubertal high-flow priapism: bilateral superselective embolisation.
47. The roles of testicular nuclear receptor 4 (TR4) in male fertility-priapism and sexual behavior defects in TR4 knockout mice.
48. Sibutramine for the treatment of recurrent high-flow priapism.
49. Sonographic diagnosis of a posttraumatic arteriocavernosal fistula resulting in high-flow priapism.
50. Malignant priapism secondary to metastatic prostate cancer: a case report and review of literature.
51. Treating stuttering priapism.
52. Potential risks of chronic sildenafil use for priapism in sickle cell disease.
53. Priapism due to a single dose of quetiapine: a case report.
54. Persistent penile erection (priapism) after acepromazine premedication in a gelding.
55. High Dosage of Aripiprazole Induced Priapism: A Case Report.
56. Penile necrosis due to priapism developed after circumcision in a patient with protein S deficiency.
57. Castration for treating recurrent priapism: can we do better?
58. [Prostatic neuroendocrine carcinoma with priapism : a case report].
59. A case of relapsing priapism associated with long-acting injectable risperidone.
60. Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy.
61. Posttraumatic priapism in child.
62. Priapism following a lumbar sympathetic nerve block.
63. Early insertion of inflatable prosthesis for intractable ischemic priapism: our experience and review of the literature.
64. Priapism in acute spinal cord injury.
65. Microcoil embolization in post-traumatic high-flow priapism.
66. Priapism: new concepts in medical and surgical management.
67. Towards evidence based emergency medicine: Best BETs from the Manchester Royal Infirmary. Bet 1: The effectiveness of oral terbutaline in treatment of priapism.
68. Adrenergic α-blockers: an infrequent and overlooked cause of priapism.
69. New insights into the pathophysiology of sickle cell disease-associated priapism.
70. Priapism in sickle-cell disease: a hematologist's perspective.
71. Sickle-cell priapism--a series of informational articles and a call to action by the medical community.
72. High flow priapism: diagnosis and treatment in pediatric population.
73. [Acute priapism associated with sickle cell disease in Senegal: clinical, therapeutic features and risk factors for erectile dysfunction].
74. Priapism in sickle cell anemia: emerging mechanistic understanding and better preventative strategies.
75. Incidence and clinical features of priapism in Japan: 46 cases from the Japanese diagnosis procedure combination database 2006-2008.
76. Priapism in the United States: the changing role of sickle cell disease.
77. Words of wisdom. Re: Ketoconazole and prednisone to prevent recurrent ischemic priapism.
78. Priapism in hematological and coagulative disorders: an update.
79. A case of recurrent priapism in the context of quetiapine use, discontinuation, and rechallenge.
80. Malignant priapism secondary to osteogenic sarcoma.
81. Continuous epidural blockade for treatment of drug-induced priapism.
82. Priapism during treatment with olanzapine, quetiapine, and risperidone in a patient with schizophrenia: a case report.
83. Management of priapism: a case report.
84. Priapism during transurethral surgery under spinal anaesthesia: Implications and review of management options.
85. Heparin and prednisone-associated priapism: two case reports.
86. Priapism in the newborn: management and review of literature.
87. [Priapism: a severe paediatric complication of Fabry disease].
88. Posttraumatic high-flow priapism in children treated with autologous blood clot embolization: long-term results and review of the literature.
89. A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial--the priapism in sickle cell study.
90. Daily phosphodiesterase type 5 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation.
91. Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue.
92. Priapism associated with methylphenidate: a case report.
93. Words of wisdom. Re: corporal "snake" maneuver: corporaglanular shunt surgical modification for ischemic priapism.
94. Malignant priapism: a case report.
95. In vitro and in vivo animal models in priapism research.
96. Stuttering priapism: case report and bibliographic review.
97. Ischemic priapism and implant surgery with sharp corporal fibrosis excision.
98. Propofol and priapism.
99. Idiopathic high-flow priapism in a pediatric patient.
100. Recent advances in the medical and surgical treatment of priapism.
101. Erectile function and dysfunction following low flow priapism: a comparison of distal and proximal shunts.
102. [Priapism: current understanding].
103. [Corpus cavernosum-corpus spongiosum shunt plus intracavernous tunneling for the treatment of prolonged ischemic priapism].
104. Priapism resulting from sertralinerisperidone combination in a 30-year-old Nigerian man with schizophrenia.
105. Penile amputation after trazodone-induced priapism: a case report.
106. Priapism caused by cavernosal arterio-lacunar fistula during hemodialysis: a case report.
107. From methylene blue (methylthionine chloride) to Al-Ghorab procedure: the therapy of priapism (our experience).
108. Antipsychotic-induced priapism in an HIV patient: a cytochrome P450-mediated drug interaction.
109. A crackling priapism related to Fournier's gangrene in a patient on chronic peritoneal dialysis.
110. Post-traumatic high-flow priapism treated by endovascular embolization using N-butyl-cyanoacrylate.
111. Priapism and Irukandji syndrome.
112. [Priapism secondary to treatment due to cabergoline: the first description of this association].
113. Al-Ghorab Shunt plus intracavernous tunneling for prolonged ischemic priapism.
114. Androgen blockade for the treatment of high-flow priapism.
115. The use of high-resolution magnetic resonance imaging in the management of patients presenting with priapism.
116. Diagnostic and therapeutic options for the management of ischemic and nonischemic priapism.
117. Outcome of management of acute prolonged priapism in patients with homozygous sickle cell disease.
118. Management of ischemic priapism by penile prosthesis insertion: prevention of distal erosion.
119. Sexual dysfunction: immediate penile prosthesis for acute ischemic priapism.
120. Priapism. Case report.
121. [Emergency checklist: priapism].
122. [Superselective transarterial coil embolization for therapy of high-flow priapism: a case report].
123. An animal model of ischemic priapism and the effects of melatonin on antioxidant enzymes and oxidative injury parameters in rat penis.
124. Fabry disease and G6PD in three family members with priapism: is the nitric oxide pathway to blame?
125. Priapism: pathogenesis, epidemiology, and management.
126. The actual incidence of papaverine-induced priapism in patients with erectile dysfunction following penile colour Doppler ultrasonography.
127. Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity.
128. Malignant priapism secondary to adenocarcinoma of the prostate.
129. Priapism and risperidone.
130. High-flow priapism in a 12-year-old boy: Treatment with superselective embolization.
131. High-flow priapism due to a malignant glomus tumor (glomangiosarcoma) of the corpus cavernosum.
132. Priapism and penile gangrene due to thrombotic thrombocytopenic purpura.
133. Refractory priapism associated with ingestion of yohimbe extract.
134. Clinical image. High-flow priapism after perineal trauma.
135. Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling.
136. Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism.
137. Orthostatic stuttering priapism in a HIV positive man.
138. Malignant priapism secondary to testicular tumor.
139. Priapism associated with Latrodectus mactans envenomation.
140. Structural analysis of the corpora cavernosa in patients with ischaemic priapism.
141. Risperidone-induced priapism: a case report.
142. Materials in embolotherapy of high-flow priapism: results and long-term follow-up.
143. Priapism secondary to penile metastasis of rectal cancer.
144. Priapism as the first manifestation of chronic myeloid leukemia.
145. [Priapism].
146. Ketoconazole and prednisone to prevent recurrent ischemic priapism.
147. Colour duplex ultrasound and simplified corporoglanular shunting procedures with and without tunnelling in contemporary management of priapism.
148. Colour Doppler ultrasound hemodynamic characteristics of patients with priapism before and after therapeutic interventions.
149. The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway.
150. Priapism: a rare complication following epidural analgesia.
151. Posttraumatic high-flow priapism: case report, current management options and literature review.
152. Oral midodrine for prostaglandin e1 induced priapism in spinal cord injured patients.
153. Treatment of recurrent priapism in sickle cell anemia with finasteride: a new approach.
154. Priapism in infantile transverse myelitis.
155. Priapism associated with olanzapine.
156. Clitoral priapism with no known risk factors.
157. [Malignant priapism and secondary bladder cancer].
158. [Priapism secondary to penis infiltration of bladder cancer].
159. Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism.
160. Priapism in dogs.
161. Increased cavernosal relaxations in sickle cell mice priapism are associated with alterations in the NO-cGMP signaling pathway.
162. Anxiety disorders in patients with idiopathic priapism: risk factor and pathophysiologic link?
163. Priapism in children: review of pathophysiology and treatment.
164. Oral phosphodiesterase type 5 inhibitors alleviate recurrent priapism complicating thalassemia intermedia: a case report.
165. Evaluation and management of priapism: 2009 update.
166. Partial priapism secondary to tamsulosin: a case report and review of the literature.
167. [A case of penile metastasis of malignant melanoma with priapism].
168. Successful treatment of propofol-induced priapism with distal glans to corporal cavernosal shunt.
169. Case 1: An unusual cause of headaches and priapism in a teenager.
170. [Aripiprazole and priapism].
171. Recurrent idiopathic high-flow priapism treated with selective arterial embolization after repeated initial treatments for low-flow priapism.
172. Priapism as a complication after total hip arthroplasty: a case report and review of the literature.
173. Adenosine signaling, priapism and novel therapies.
174. Priapism as an unusual manifestation of catatonia: a case report.
175. T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism.
176. Valsalva maneuver-induced priapism: a hidden culprit.
177. Corporal "snake" maneuver: corporoglanular shunt surgical modification for ischemic priapism.
178. Successful use of terbutaline in persistent priapism in a 12-year-old boy with chronic myeloid leukemia.
179. Favorable response to intrathecal, but not oral, baclofen of priapism in a patient with spinal cord injury.
180. Recurrent priapism in sickle cell trait with protein S deficiency.
181. Resolution of recurrent ischemic priapism after celiac plexus block: case report evidence for its neurogenic origin?
182. Psychiatric treatment of patients predisposed to priapism induced by quetapine, trazadone and risperidone: a case report.
183. Clinical experience and sexual function outcome of patients with priapism treated with penile cavernosal-dorsal vein shunt using saphenous vein graft.
184. Sickle cell trait and priapism: a case report and review of the literature.
185. High-flow priapism undergoing arterial embolization: review of literature following American Urological Association guideline on the management of priapism.
186. Against: No surgery for stuttering priapism.
187. For: Surgery for stuttering priapism.
188. Priapism secondary to perineal abscess in a dog - a case report.
189. [Priapism following off-label use of tamulosin].
190. T-shunt with or without tunnelling for prolonged ischaemic priapism.
191. [Diagnosis and treatment of priapism: a report of 15 cases].
192. Intracavernous epinephrine: a minimally invasive treatment for priapism in the emergency department.
193. Priapism as a manifestation of tetania.
194. Successful treatment of idiopathic priapism in a 13-year-old boy.
195. [Case report of post-traumatic arterial high-flow priapism].
196. [Priapism associated with antipsychotic medications: a series of four patients].
197. Appendicitis and low-flow priapism in children.
198. A modification of Winter's shunt in the treatment of pediatric low-flow priapism.
199. Approach to newborn priapism: a rare entity.
200. Management of high-flow priapism in paediatric patients: a case report and review of the literature.
201. Recurrent priapism in the young patient treated with baclofen.
202. Temporary cavernosal-cephalic vein shunt in low-flow priapism treatment.
203. Editorial comment on: Temporary cavernosal-cephalic vein shunt in low-flow priapism treatment.
204. Editorial comment on: Temporary cavernosal-cephalic vein shunt in low-flow priapism treatment.
205. The immediate insertion of a penile prosthesis for acute ischaemic priapism.
206. Pediatric high-flow priapism and super-selective angiography--an Australian perspective.
207. Idiopathic low-flow priapism in prepuberty: a case report and a review of literature.
208. Glucose-6-phosphate dehydrogenase deficiency associated stuttering priapism: report of a case.
209. [Priapism secondary to penis infiltration of bladder cancer].
210. Clinical course linkage among different priapism subtypes: Dilemma in the management strategies.
211. Chemotherapeutic treatment of priapism in metastatic rectal cancer.
212. Magnetic resonance imaging of partial segmental priapism (segmental thrombosis of corpus cavernosum).
213. Images in emergency medicine. Low-flow (ischemic) priapism.
214. Stuttering priapism complicating warfarin therapy in a patient with protein C deficiency.
215. High-flow priapism: superselective cavernous artery embolization with microcoils.
216. Priapism, ecstasy, and marijuana: is there a connection?
217. Color Doppler appearance of penile cavernosal-spongiosal communications in patients with high-flow priapism.
218. The investigation of putative agents, using an in vitro model, to prevent cavernosal smooth muscle dysfunction during low-flow priapism.
219. Expression and activity of heme oxygenase-1 in artificially induced low-flow priapism in rat penile tissues.
220. Treatment of idiopathic recurrent priapism with fluoxetine and low dose Perphenazine.
221. Conservative management of priapism secondary to leukemia.
222. Stuttering priapism--a review of the therapeutic options.
223. Investigating the effects of high-dose phenylephrine in the management of prolonged ischaemic priapism.
224. Priapism in a 15-year-old boy with major beta-thalassemia.
225. High-flow priapism complicating ischemic priapism following iatrogenic laceration of the dorsal artery during a Winter procedure.
226. [Arterial microcoil embolization in high flow priapism].
227. Adrenergic crisis after penile epinephrine injection for priapism.
228. Penile prosthesis, spinal anesthesia, and priapism.
229. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling.
230. Sickle cell disease status and outcomes of African-American men presenting with priapism.
231. Use of magnetic resonance angiography in diagnosis and decision making of post-traumatic, high-flow priapism.
232. Recurrent priapism related to oxaliplatin infusion.
233. [Intermittent priapism as the clinical presentation of a narrow lumbar canal].
234. Subarachnoid hemorrhage as complication of phenylephrine injection for the treatment of ischemic priapism in a sickle cell disease patient.
235. Posttraumatic nonischemic priapism treated with autologous blood clot embolization.
236. Priapism associated with atypical antipsychotic medications: a review.
237. Insights of priapism mechanism and rationale treatment for recurrent priapism.
238. The physical, social and psychological impact of priapism on adult males with sickle cell disorder.
239. A case report on idiopathic recurrent priapism.
240. Immediate insertion of a semirigid penile prosthesis for refractory ischemic priapism.
241. Hemoglobin-E beta thalassemia presenting with recurrent priapism--a rare complication.
242. The Winter procedure as management for prolonged low-flow priapism: a case report.
243. Intermittent priapism in degenerative lumbar spinal stenosis: case report.
244. Post-surgical high-flow priapism treated by embolization.
245. Priapism: current principles and practice.
246. [Intermittent priapism as a clinical feature of lumbar spinal stenosis].
247. Glucose-6-phosphate dehydrogenase deficiency: an etiology for idiopathic priapism?
248. Priapism: reasons for failure by Frank Hinman Jr.
249. Sildenafil citrate ingestion and prolonged priapism and tachycardia in a pediatric patient.
250. Priapism in a castrated cat associated with feline infectious peritonitis.
251. Stuttering priapism associated with hereditary spherocytosis.
252. Treatment of high-flow priapism with superselective transcatheter embolization in 27 patients: a multicenter study.
253. Association between priapism and concurrent use of risperidone and Ginkgo biloba.
254. Posttraumatic high-flow priapism in children: noninvasive treatment by color Doppler ultrasound-guided perineal compression.
255. Priapism--a rare complication following continuous epidural morphine and bupivacaine infusion.
256. Words of wisdom. Re: feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism.
257. [Priapism in sickle cell anaemia in Senegal: prevalence, attitudes and knowledge].
258. Risperidone-induced priapism in a 12-year-old boy with schizophrenia.
259. Recurrent priapism during treatment with clozapine, quetiapine and haloperidol.
260. Management of priapism in a child with sickle cell anemia; successful outcome using epidural analgesia.
261. [Our experience in high-flow priapism due to uni-or bilateral arterio-lacunar fistula].
262. The use of transcatheter superselective embolization to treat high flow priapism (arteriocavernosal fistula) caused by straddle injury.
263. [Diagnosis and treatment of veno-occlusive priapism (a report of 17 cases)].
264. [Low flow priapism. Treatment by sapheno-cavernous shunt].
265. Priapism associated with sertraline.
266. [Priapism complicated by chronic myelogenous leukemia (CML); a case report].
267. Penile erection of pathological source; semantically a better term for priapism.
268. Post traumatic prepubertal high-flow priapism: a rare occurrence.
269. [Stuttering priapism in children with sickle cell anemia in Togo].
270. Superselective arterial embolization for patients with high-flow priapism: results of follow-up for five or more years.
271. New-onset priapism associated with ingestion of terazosin in an otherwise healthy man.
272. Treatment of posttraumatic high-flow priapism in 8-year-old boy with percutaneous ultrasound-guided thrombin injection.
273. Priapism in the oncology setting.
274. Successful superselective arterial embolization for post-traumatic high-flow priapism.
275. Priapism in children: treatment with embolotherapy.
276. Genetic polymorphisms associated with priapism in sickle cell disease.
277. Risperidone-induced priapism.
278. Low-flow priapism needs recognition and early correct treatment.
279. Priapism: diagnosis and early referral in emergency departments.
280. Priapism: an unusual manifestation of warfarin-induced skin necrosis with protein C deficiency.
281. Priapism with sertraline-risperidone combination.
282. Myth: blood transfusion is effective for sickle cell anemia-associated priapism.
283. Hematological parameters in sickle cell anemia patients with and without priapism.
284. Priapism associated with the switch from oral to injectable risperidone.
285. Spontaneous resolution of delayed onset, posttraumatic high-flow priapism.
286. Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism.
287. Long standing priapism as presentation of lymphoma.
288. High-flow priapism: An overview of diagnostic and therapeutic concepts.
289. Stuttering priapism after ingestion of alfuzosin.
290. Priapism and quetiapine: a case report.
291. Priapism: new concepts in the pathophysiology and new treatment strategies.
292. [Priapism in childhood--case report of 14-year-old boy].
293. Recurrent priapism associated with use of aripiprazole.
294. Tardive priapism associated with clozapine. A case report.
295. Management of ischemic priapism with high-dose intracavernosal phenylephrine: from bench to bedside.
296. [High flow priapism. Case report].
297. Spontaneous priapism after radical retropubic prostatectomy.
298. Neonatal priapism associated with spontaneous bilateral pyocavernositis.
299. Distal cavernosum-glans shunts for ischemic priapism.
300. Nitric oxide in the penis--science and therapeutic implications from erectile dysfunction to priapism.
301. [Priapism in a child with chronic myelogenous leukemia: a case report].
302. Priapism related to an antiphospholipid syndrome in a patient with systemic lupus erythematosus.
303. [Priapism: diagnosis and treatment].
304. [Intracavernosal methoxamine self-injection for the treatment of low-flow recurrent priapism].
305. [Priapism associated with quetiapine in an elderly patient].
306. Tricorporal priapism postradical cystoprostatectomy: first sign of recurrent urogenital malignancy.
307. Priapism of the clitoris.
308. Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism.
309. Priapism associated with typical and atypical antipsychotic medications.
310. Priapism in an infant caused by post-operative analgesia through epidural catheter.
311. Propofol-induced priapism, a case confirmed with rechallenge.
312. Pathology of "Berkeley" sickle-cell mice includes gallstones and priapism.
313. [Diagnosis and treatment of priapism due to neoplasma of penis].
314. Testosterone-induced priapism in Klinefelter syndrome.
315. [Non traumatic high flow priapism: arterial embolization treatment].
316. An alternative noninvasive approach for the treatment of high-flow priapism in a child: duplex ultrasound-guided compression.
317. Therapy insight: Priapism associated with hematologic dyscrasias.
318. Erectile dysfunction and priapism.
319. Medical and surgical management of priapism.
320. Evaluation of patients after treatment of arterial priapism with selective micro-embolization.
321. [Priapism].
322. Priapism.
323. Idiopathic stuttering priapism treated successfully with low-dose ethinyl estradiol: a single case report.
324. Priapism and quetiapine in an HIV-positive male.
325. Case report: Avoidance of palpable corporal fibrosis due to priapism with upregulators of nitric oxide.
326. Ziprasidone-induced priapism requiring surgical treatment.
327. Treatment of "high-flow" priapism with superselective transcatheter embolization: a useful alternative to surgery.
328. [History of high-flow priapism: 1960-2005].
329. Post-traumatic high flow priapism percutaneously treated with transcatheter embolisation.
330. Priapism associated with oxcarbazepine, aripiprazole, and lithium.
331. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.
332. Priapism associated with routine use of quetiapine: case report and review of the literature.
333. Intracavernous papaverine/phentolamine-induced priapism can be accurately predicted with color Doppler ultrasonography.
334. A rare case of penile metastasis of testicular cancer presented with priapism.
335. High-flow priapism as a complication of a veno-occlusive priapism: two case reports.
336. Priapism in sickle cell disease.
337. [Long-term high-flow priapism. Case review and proposal of diagnostic algorithm and treatment].
338. Traumatic high-flow priapism: treatment with super-selective micro-coil embolization.
339. Thrombosis and priapism in a patient with Henoch-Schonlein purpura.
340. [Management of priapism in patients with sickle-cell anaemia].
341. Is the combination of superselective transcatheter autologous clot embolization and duplex sonography-guided compression therapy useful treatment option for the patients with high-flow priapism?
342. [Integrated treatment for priapism caused by circumcision: a case report].
343. Tadalafil-associated priapism.
344. [Transitional carcinoma and malignant priapism].
345. [Priapism and activated protein C resistance].
346. Hemolysis-associated priapism in sickle cell disease.
347. High-flow priapism in testosterone-treated boys with constitutional delay of growth and puberty may occur even when very low doses are used.
348. Mycoplasma-enhanced priapism in mice.
349. Priapism caused by 'All Nite Long'.
350. [Erection due to 'high flow' priapism in a 5-year old: an emergency].
351. [Erection due to 'high flow' priapism in a 5-year old: an emergency].
352. [Erection due to 'high flow' priapism in a 5-year old: an emergency].
353. [Erection due to 'high flow' priapism in a 5-year old: an emergency].
354. Conservative management of priapism in acute spinal cord injury.
355. Intracavernosal etilefrine self-injection therapy for recurrent priapism: one decade of follow-up.
356. Prostate abscess presenting as priapism.
357. Juvenile posttraumatic high-flow priapism: current management dilemmas.
358. Priapism following oral sildenafil abuse.
359. Does prolonged semi-erection in prepubertal high flow priapism result in increased penile size?
360. [Successful treatment of high-flow priapism by selective arteriographic embolization of the pudendal artery].
361. [Erection due to 'high flow' priapism in a 5-year old: an emergency].
362. Priapism - etiology, pathophysiology and management.
363. Successful management of stuttering priapism using home self-injections of the alpha-agonist metaraminol.
364. High-flow priapism (HFP) secondary to Nesbit operation: management by percutaneous embolization and colour Doppler-guided compression.
365. Priapism due to sacrococcygeal chordoma metastasis treated with radiation therapy.
366. Priapism.
367. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism.
368. 38-year-old man with priapism and a history of paranoid schizophrenia.
369. [Resolution of a case of arterial priapism secondary to bilateral arteriocavernous fistula with selective embolization using reabsorbible material].
370. Long duration priapism in blast crisis of chronic myeloid leukemia.
371. Occurrence of priapism with risperidone-paroxetine combination in an autistic child.
372. Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia.
373. [Priapism].
374. Is antidepressant plus sildenafil a recipe for priapism?
375. Penile fracture in a patient with stuttering priapism.
376. Unresolved priapism secondary to tamsulosin.
377. Priapism as a presentation of T-cell acute lymphoblastic leukaemia in a child.
378. [Arterial priapism in a prepuberal patient. Conservative treatment].
379. Paediatric priapism--treatment conundrum.
380. Cold saline enema in priapism--a useful tool for underprivileged.
381. Treatments for priapism in boys and men with sickle cell disease.
382. High-flow priapism: colour-Doppler ultrasound-guided supraselective embolization therapy.
383. [Priapism following paraneoplastic leukemoid reaction in a patient with bladder cancer].
384. Superselective embolization in posttraumatic priapism with glubran 2 acrylic glue.
385. Priapism secondary to leukemia: effective management with prompt leukapheresis.
386. [One case report of clitoral priapism and literature review].
387. Olanzapine-induced clitoral priapism.
388. High-flow priapism of unknown etiology in a prepubertal boy.
389. Follow-up of sickle cell disease patients with priapism treated by hydroxyurea.
390. Idiopathic intracranial hypertension: priapism of the brain?
391. TGF-beta1 neutralizing antibodies decrease the fibrotic effects of ischemic priapism.
392. Persistent priapism and histological modifications of the erectile tissue. Two case reports.
393. [Priapism as an initial presentation of chronic myeloid leukaemia].
394. Priapism in southwestern Nigeria.
395. Sexual function after highly selective embolization of cavernous artery in patients with high flow priapism: long-term followup.
396. Three-chamber priapism in a patient with primary epithelioid hemangioendothelioma of penis.
397. Use of antivenin to treat priapism after a black widow spider bite.
398. Changing diagnostic and therapeutic concepts in high-flow priapism.
399. Risperidone-induced priapism with rechallenge.
400. [Post-traumatic high-flow priapism in an adolescent].
401. High-flow priapism in acute lymphatic leukaemia.
402. Low molecular weight heparin induced priapism.
403. [Diagnosis and therapy of different types of priapism].
404. Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction.
405. [Post-traumatic high-flow priapism: a case report].
406. Idiopathic stuttering priapism: recovery of detumescence mechanism with temporal use of antiandrogen.
407. Priapism as a possible acute side effect of radical radiotherapy for prostate cancer.
408. Irreversible priapism during olanzapine and lithium therapy.
409. Priapism.
410. Stuttering priapism associated with withdrawal from sustained-release methylphenidate.
411. [Metachronous recurrence of idiopathic high flow priapism].
412. Transitional cell carcinoma presenting as clitoral priapism.
413. [High flow arterial priapism secondary to post-traumatic bilateral arterio-cavernous fistula. Highly selective embolization with autologous blood clot].
414. Investigation of cavernosal smooth muscle dysfunction in low flow priapism using an in vitro model.
415. Emergency evaluation and treatment of priapism.
416. High flow priapism secondary to internal urethrotomy treated with embolization.
417. Treatment of priapism in pediatric patients with sickle cell disease.
418. Behçet's disease presenting as deep venous thrombosis and priapism.
419. Priapism as the presenting symptom of an aortocaval fistula.
420. Gabapentin in the management of the recurrent, refractory, idiopathic priapism.
421. The value of penile duplex in the prediction of intracavernous drug-induced priapism.
422. Acenocoumarol associated priapism: report of a case.
423. Management of recurrent priapism in a cervical spinal cord injury patient with oral baclofen therapy.
424. Priapism.
425. Priapism in a semiwild Asian elephant (Elephas maximus) in Vietnam.
426. Successful treatment with clozapine at higher doses after clozapine-induced priapism.
427. Priapism--a review of the medical management.
428. High-flow priapism caused by injury of the bilateral cavernosal artery after needle trauma in a patient with low-flow priapism.
429. Of gods and leeches: treatment of priapism in the nineteenth century.
430. Evidence-based radiology problems. High-flow post-traumatic priapism: transcatheter embolotherapy: October 2003-September 2004.
431. Non surgical treatment of recurrent or stuttering priapism in sickle cell children.
432. Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy.
433. The treatment of priapism--when and how?
434. Priapism pathophysiology: clues to prevention.
435. Reperfusion of ischemic corporal tissue: physiologic and biochemical changes in an animal model of ischemic priapism.
436. Novel technique in the management of low flow priapism.
437. Priapism induced by proton-pump inhibitors and misoprostol.
438. American Urological Association guideline on the management of priapism.
439. Priapism: an appraisal of surgical treatment.
440. Priapism in a patient with unstable hemoglobin: hemoglobin Köln.
441. The incidence and management of priapism in Western Australia: a 16 year audit.
442. [Spontaneous high flow arterial priapism of old males(one case report and review)].
443. Efficacy of shunt surgery for refractory low flow priapism: a report on the incidence of failed detumescence and erectile dysfunction.
444. [A case of post-traumatic high flow priapism].
445. Priapism at age 94.
446. [Penile angiography and superselective embolization therapy in arterial priapism].
447. [Pediatric priapism associated with pulmonary infection].
448. Re: Chronic myeloid leukaemia presenting as priapism in children: need for multidisciplinary approach.
449. Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism.
450. Priapism of the glans and corpus spongiosum. Report of two cases with angiography.
451. Priapism--a rare presentation in chronic myeloid leukemia: case report and review of the literature.
452. Priapism in a patient receiving long-term chlorpromazine therapy. A case report.
453. Cocaine and ephedrine-induced priapism: case reports and investigation of potential adrenergic mechanisms.
454. Olanzapine-associated priapism.
455. Malignant priapism secondary to bladder cancer.
456. Tricorporal priapism in a patient with metastatic esophageal cancer.
457. Pathophysiology of priapism: dysregulatory erection physiology thesis.
458. Management of post-traumatic arterial priapism in children: presentation of a case and review of the literature.
459. Priapism following ingestion of tamsulosin.
460. [Malignant priapism as a sign of a recurrent prostate cancer. Differential diagnosis of induratio penis plastica].
461. Management of low-flow priapism using the Winter procedure: a case report.
462. Bilateral superselective arterial microcoil embolization in post-traumatic high-flow priapism: a case report.
463. Idiopathic priapism in a young boy.
464. [High-flow priapism. Echographic diagnosis and treatment using selective embolization of the cavernous artery].
465. [Priapism in the stallion and in man].
466. A case of risperidone-induced priapism.
467. Priapism caused by infection and an inflammatory process in the pelvic region.
468. Color Doppler imaging of posttraumatic priapism before and after selective embolization.
469. Successful treatment of arterial priapism with radiologic selective transcatheter embolization of the internal pudendal artery.
470. Priapism associated with risperidone: a case report.
471. Paraphimosis/priapism in rabbits.
472. A clinical case report of priapism treated with external RT.
473. Testosterone induced priapism in Kallmann's syndrome.
474. Priapism secondary to hypertriglyceridemia.
475. Management of priapism in the newborn.
476. [Priapism in the stallion].
477. Post-splenectomy veno-occlusive priapism in a child with idiopathic thrombocytopenic purpura.
478. [Management of priapism in sickle-cell diseases with alpha-adrenergic agonists].
479. Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study.
480. The management of low-flow priapism with the immediate insertion of a penile prosthesis.
481. Pseudo-priapism! Forgotten semirigid penile prosthesis.
482. [Priapism in the course of generalized atopic dermatitis].
483. Treatment of recurrent idiopathic priapism with oral baclofen.
484. Interventional treatment of traumatic priapism.
485. The etiology, diagnosis, and treatment of priapism: review of the American Foundation for Urologic Disease Consensus Panel Report.
486. Clitoral priapism: a rare condition presenting as a cause of vulvar pain.
487. Priapism associated with hemoglobin C trait.
488. Management strategy for arterial priapism: therapeutic dilemmas.
489. Reversible penile priapism associated with nefazodone.
490. [High-flow priapism caused by bilateral arterio-lacunar fistula].
491. Henoch-Schönlein purpura and priapism.
492. Superselective embolization with coils in high-flow priapism.
493. MRI and color-coded duplex sonography: diagnosis of partial priapism.
494. Sildenafil relieves priapism in patients with sickle cell disease.
495. Traumatic arterial priapism: case report and discussion of a rare urologic injury.
496. Etilefrine for the prevention of priapism in adult sickle cell disease.
497. Priapism associated with two atypical antipsychotic agents.
498. [The occurrence of priapism on introduction of anti-vitamin K, revealing a constitutional thrombophilia].
499. Antiandrogens in the treatment of priapism.
500. Priapism secondary to penile metastasis in a dog.
501. Priapism associated with trazodone in an adolescent with autism.
502. The aetiology, pathogenesis and management of priapism.
503. [Priapism secondary to chronic myeloid leukemia: value of initial treatment with cavernous lavage plus adjuvant methoxamine].
504. [Methylene blue: an effective therapeutic alternative for priapism induced by intracavernous injection of vasoactive agents].
505. High flow priapism due to an arterial-lacunar fistula complicating initial veno-occlusive priapism.
506. [A report of two cases of priapism with metastatic penile tumor].
507. [Metastatic penile lesions secondary to transitional cell carcinoma of the bladder: a rare cause of "malignant priapism"].
508. Priapism associated with zuclopenthixol.
509. Risperidone-induced priapism.
510. Priapism: a medical emergency.
511. Risperidone-associated priapism in an elderly man.
512. An experience of percutaneous embolization to post-traumatic arterial priapism in a child.
513. Successful treatment of arterial priapism with alpha-agonist irrigation: a rural experience.
514. Citalopram-induced priapism.
515. High-flow priapism: a combined interventional approach with angiography and colour Doppler.
516. Sildenafil induced priapism.
517. Exacerbation of idiopathic priapism with risperidone-citalopram combination.
518. Short period of administration of diethylstilbestrol in stuttering priapism in sickle cell anemia.
519. Acute priapism in a patient with unstable hemoglobin Perth and Factor V Leiden under effective oral anticoagulant therapy.
520. Heparin-induced priapism.
521. Highly selective embolization of bilateral cavernous arteries for post-traumatic penile arterial priapism.
522. Post-traumatic high flow priapism: demonstrable findings of penile enhanced computed tomography.
523. Epidural analgesia in a child with sickle cell disease complicated by acute abdominal pain and priapism.
524. Low-flow priapism: risk factors for erectile dysfunction.
525. [Embolization of the bilateral internal pudendal arteries for intractable priapism in a child with chronic myelogenous leukemia].
526. Antiandrogens in the treatment of priapism.
527. High-flow priapism: treatment and long-term follow-up.
528. Priapism in sickle cell anemia in Togo: prevalence and knowledge of this complication.
529. Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism.
530. High flow priapism due to a bilateral arteriosinusoidal fistula--an unusual conservative treatment.
531. Priapism in a 15-year-old boy with congenital dyserythropoietic anemia type II (hereditary erythroblastic multinuclearity with positive acidified serum lysis test).
532. Continuation of clozapine after priapism.
533. Olanzapine-induced priapism.
534. High-flow priapism in children: immediate treatment by selective embolization.
535. [Priapism and low-molecular-weight heparin. Case report].
536. [Priapism secondary to testosterone administration in the treatment of delayed puberty].
537. Successful treatment of low-flow priapism associated with phenothiazine therapy.
538. Urethrocutaneous fistula as a severe complication of treatment for priapism.
539. Priapism: a review.
540. Arterial priapism and cycling: a new worrisome reality?
541. Priapism from quetiapine overdose: first report and proposal of mechanism.
542. [Post-traumatic high flow priapism in a child].
543. Post traumatic high-flow arterial priapism. The need for increased awareness among health care professionals.
544. [Priapism: decisional algorithm, our experience, and role of sildenafil in sexual rehabilitation].
545. Prepubertal high flow priapism: incidence, diagnosis and treatment.
546. Priapism associated with intracavernosal injection of cocaine.
547. Successful treatment of recalcitrant priapism using intercorporeal injection of tissue plasminogen activator.
548. [Incidence of priapism at the Marqués de Valdecilla University Hospital in Santander].
549. [Surgical treatment of priapism with open glans penis puncture-drainage in 26 black patients].
550. Post-traumatic high-flow priapism: management by superselective transcatheter autologous clot embolization and duplex sonography-guided compression.
551. Management of sickle cell priapism with etilefrine.
552. Intracavernosal adrenalin injection in priapism.
553. Priapism associated with conventional and atypical antipsychotic medications: a review.
554. Priapism. From Priapus to the present time.
555. Recanalization of embolized cavernosal artery: restoring potency in the patient with high flow priapism.
556. [Emergencies in general practice, 11. Priapism: diagnosis and therapy].
557. Incidence of priapism in the general population.
558. Priapism after a suicide attempt by ingestion of olanzapine and gabapentin.
559. Intracavernosal phenylephrine for recurrent priapism: self-administration by drug delivery implant.
560. High-flow priapism: a novel way of lateralizing the lesion in radiologically inapparent cases.
561. Acute appendicitis presenting as priapism in an 8 year old.
562. Priapism in type 2 diabetes mellitus.
563. Olanzapine-associated priapism.
564. [Heparin-induced priapism].
565. Endovascular therapy for priapism secondary to perineal trauma.
566. Priapism as the first sign of a pelvic tumour in a two-and-a-half-year-old boy.
567. Priapism associated with polypharmacy.
568. Priapism is rare in sickle cell disease in India.
569. Malignant priapism associated with metastatic urethral carcinoma.
570. Bilateral superselective arterial microcoil embolisation in delayed post-traumatic high flow priapism.
571. [Low-flow priapism associated with systemic lupus erythematosus and nephrotic syndrome].
572. [Diagnosis and therapeutic options for prolonged erection and priapism: up-date review].
573. [A case of traumatic priapism].
574. [Trazodone-induced priapism].
575. [Spontaneous autoembolization in a child with high-flow post-traumatic priapism].
576. The prediction of papaverine induced priapism by color Doppler sonography.
577. Methylene blue as a successful treatment alternative for pharmacologically induced priapism.
578. Management of partial segmental priapism.
579. Recurrent priapism during treatment with clozapine and olanzapine.
580. Stuttering priapism in a liver transplant patient with toxic levels of fk506.
581. Post-traumatic, high-flow priapism treated with selective cavernous artery embolization and intracavernous streptokinase irrigation: a case report.
582. The incidence of pharmacologically induced priapism in the diagnostic and therapeutic management of 685 men with erectile dysfunction.
583. Treatment of long-lasting priapism in chronic myeloid leukemia at onset.
584. Selective arterial embolization for post-traumatic high flow priapism.
585. Refractory priapism of unknown etiology in a pediatric patient.
586. Priapism.
587. [Surgical treatment of priapism: experience of 56 cases in an African setting].
588. [Sickle cell disease priapism: treatment with intracavernous injections of etilefrine].
589. Priapism of ambiguous classification in a sickle cell patient.
590. Megalophallus as a sequela of priapism in sickle cell anemia: use of blood oxygen level-dependent magnetic resonance imaging.
591. [Metastasis priapism. Report of 4 new cases and review of the literature].
592. Posttraumatic high-flow priapism: treatment with selective embolisation.
593. Traumatic priapism: an unusual cycling injury.
594. [Priapism: decisional algorithm. Our experience and role of sildenafil in sexual rehabilitation].
595. [Post-traumatic priapism with high flow treated with embolization with N-butyl-cyanoacrylate. Apropos of a case].
596. Unusual complications of warfarin therapy: skin necrosis and priapism.
597. Undetectable serum glucose concentration in a patient with priapism.
598. Do automated red cell exchanges relieve priapism in patients with sickle cell anemia?
599. [Delayed posttraumatic high flow priapism: a case report].
600. Cavernosal spongiosium shunt in the management of priapism in Zaria, Nigeria.